{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:28:50Z","timestamp":1789972130518,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.joms.2014.02.036","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T01:01:28Z","timestamp":1393894888000},"page":"1456-1462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["A C-Terminal Crosslinking Telopeptide Test\u2013Based Protocol for Patients on Oral Bisphosphonates Requiring Extraction: A Prospective Single-Center Controlled Study"],"prefix":"10.1016","volume":"72","author":[{"given":"April","family":"Hutcheson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Kunchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sambrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2014.02.036_bib1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib3","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphonates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2014.02.036_bib4","first-page":"268","article-title":"Letters to the editor: Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter","year":"2003","journal-title":"Aus Dent J"},{"key":"10.1016\/j.joms.2014.02.036_bib5","unstructured":"Ruggiero S, Dodson TB, Assael LA: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw\u20142009 Update. Available at: http:\/\/www.aaoms.org\/docs\/position_papers\/bronj_update.pdf. Accessed August 10, 2012"},{"key":"10.1016\/j.joms.2014.02.036_bib6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2014.02.036_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc0808738","article-title":"Report of oesophageal cancer with oral bisphosphonate use","volume":"360","author":"Wysowski","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2014.02.036_bib8","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","article-title":"Bisphosphonate treatment for osteoporosis\u2014For whom and for how long?","volume":"366","author":"Black","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2014.02.036_bib9","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2014Where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2014.02.036_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1834-7819.2008.00078.x","article-title":"The oral health status of patients on oral bisphosphonates for osteoporosis","volume":"53","author":"Kunchur","year":"2008","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2014.02.036_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2014.02.036_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","article-title":"Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: An institutional inquiry","volume":"140","author":"Sedghizadeh","year":"2009","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.joms.2014.02.036_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"suppl 2","key":"10.1016\/j.joms.2014.02.036_bib16","first-page":"S4","article-title":"The dental implications of bisphosphonates and bone disease","volume":"50","author":"Cheng","year":"2005","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2014.02.036_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.joms.2014.02.036_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.joms.2008.01.054","article-title":"Oral bisphosphonate induced osteonecrosis: Risk factors, prediction of risk using CTX testing, prevention and treatment. Letter to the editor","volume":"66","author":"Khosla","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2011-0202","article-title":"Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: The role of RBMS3","volume":"17","author":"Nicoletti","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.joms.2014.02.036_bib21","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","article-title":"Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate related osteonecrosis of the jaws: Can they be utilized as risk markers?","volume":"22","author":"Kwon","year":"2011","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.joms.2014.02.036_bib23","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.joms.2010.05.043","article-title":"Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates","volume":"68","author":"Lazarovici","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bone.2013.08.005","article-title":"Prospective biomarker evaluation in patients with osteonecrosis of the jaw who received bisphosphonates","volume":"57","author":"Kim","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.joms.2014.02.036_bib25","first-page":"1","article-title":"C terminal crosslinking telopeptide as a serologic marker for bisphosphonate related osteonecrosis of the jaw: Review of 2 cases","volume":"79","author":"Pasoff","year":"2013","journal-title":"Journal of Canadian Dental Association"},{"issue":"suppl 1","key":"10.1016\/j.joms.2014.02.036_bib26","first-page":"S51","article-title":"Alveolar bone and the bisphosphonates","volume":"54","author":"Cheng","year":"2009","journal-title":"Aus Dent J"},{"key":"10.1016\/j.joms.2014.02.036_bib27","first-page":"504","article-title":"Transexamic acid mouthwash\u2014A prospective randomised study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions","volume":"32","author":"Carter","year":"2003","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/adj.12029","article-title":"The healing of dental extraction sockets in stable type 2 diabetics on oral hypoglycaemics: A\u00a0case controlled cohort study","volume":"58","author":"Huang","year":"2013","journal-title":"Aust Dent J"},{"key":"10.1016\/j.joms.2014.02.036_bib29","unstructured":"Oral and Maxillofacial Surgery Unit Annual Statistical returns. South Australian Dental Service. Annual Report. 2003 to 2013 South Australian Gazette Adelaide"},{"key":"10.1016\/j.joms.2014.02.036_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S8756-3282(00)00248-9","article-title":"Serum CrossLaps for monitoring the response of patients undergoing antiresorptive therapy","volume":"26","author":"Christgau","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.joms.2014.02.036_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/46.3.431a","article-title":"Circadian variation in Serum CrossLaps concentration is reduced in fasting individuals","volume":"46","author":"Christgau","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.joms.2014.02.036_bib32","series-title":"General Explanatory Notes. Medicare Benefit Arrangement. Section 13.3. Health Screening Services. Medicare Benefits Schedule Book","year":"2012"},{"key":"10.1016\/j.joms.2014.02.036_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2014.02.036_bib34","series-title":"A case cohort study of the prevention of osteonecrosis of the jaws (ONJ) in bisphosphonate patients requiring dental extractions. Presented at the 20th International Conference of Oral and Maxillofacial Surgery","author":"Cheng","year":"2011"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823911400247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027823911400247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:44:08Z","timestamp":1759509848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027823911400247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S027823911400247X"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2014.02.036","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A C-Terminal Crosslinking Telopeptide Test\u2013Based Protocol for Patients on Oral Bisphosphonates Requiring Extraction: A Prospective Single-Center Controlled Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2014.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}